Challenges in treating patients with Down's syndrome and testicular cancer with chemotherapy and radiotherapy: The Royal Marsden experience.

@article{Hafeez2007ChallengesIT,
  title={Challenges in treating patients with Down's syndrome and testicular cancer with chemotherapy and radiotherapy: The Royal Marsden experience.},
  author={Shaista Hafeez and Ricky A. Sharma and Robert A Huddart and David Paul Dearnaley and Alan H. Horwich},
  journal={Clinical oncology (Royal College of Radiologists (Great Britain))},
  year={2007},
  volume={19 2},
  pages={135-42}
}
AIMS With a life expectancy similar to the general population, greater numbers of patients with Down's syndrome are being diagnosed with testicular cancer. Learning difficulties and medical co-morbidity are common in this patient population and may lead to non-standard oncological treatment. We aimed to identify and discuss management challenges in the treatment of these patients with chemotherapy and radiotherapy and report their clinical outcome. MATERIALS AND METHODS The Royal Marsden… CONTINUE READING